4.3 Review

Obstetric antiphospholipid syndrome

期刊

LUPUS SCIENCE & MEDICINE
卷 5, 期 1, 页码 -

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/lupus-2016-000197

关键词

-

资金

  1. Hjart-Lungfonden
  2. Reumatikerforbundet
  3. Svenska Lakaresallskapet
  4. Ingegerd Johanssons fond
  5. Vetenskapsradet [2014-33867-111552-63]
  6. Stiftelsen Konung Gustaf V:s 80-arsfond
  7. Stockholms Lans Landsting (ALF)

向作者/读者索取更多资源

The present clinical and laboratory classification criteria for antiphospholipid syndrome (APS) were established in Sydney, Australia, in 2006. In this review, we focus on the obstetric subset of APS (OAPS), defined by persistent positivity for antiphospholipid antibodies together with either early recurrent pregnancy loss, early fetal death, stillbirth or premature birth <34 gestational weeks due to pre-eclampsia, eclampsia and placental insufficiency. It is important to diagnose these cases since most women suffering from OAPS can, when given appropriate treatment, have successful pregnancies. Furthermore, patients with OAPS may, depending on the antibody profile, be at enhanced risk of thrombotic events later in life. We present an update on the present knowledge of possible underlying pathogenesis, risk factors and risk estimations for adverse pregnancy outcomes before and during pregnancy, current treatment concepts, and long-term outcomes for women with OAPS and their children.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据